Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Clinical Knowledge Summaries (CKS)
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Life sciences
More from NICE
Home
NICE guidance
Published
Published: Guidance, quality standards and advice
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic prioritisation
Filter (1 applied)
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
Antimicrobial prescribing (28)
COVID-19 (13)
Type
Type
Guidance (1254)
NICE advice (212)
Quality standard (130)
Guidance programme
Guidance programme
Antimicrobial prescribing guidelines (21)
Antimicrobial resistance guidance (2)
Clinical guidelines (174)
COVID-19 rapid guidelines (6)
HealthTech guidance (123)
Highly specialised technologies guidance (29)
Interventional procedures guidance (229)
Medicines practice guidelines (2)
NICE guidelines (234)
Public health guidelines (25)
Social care guidelines (40)
Technology appraisal guidance (637)
Advice programme
Advice programme
Evidence summaries (20)
Medtech innovation briefings (192)
Apply filters
Showing 11 to 20 of 1596
Sort by
Date
Title
Apply sorting
Last updated date between: 1/7/2016 and 9/8/2025
Remove Last updated date between: 1/7/2016 and 9/8/2025 filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Letermovir for preventing cytomegalovirus infection after a kidney transplant (terminated appraisal)
TA1082
23 July 2025
23 July 2025
Lisocabtagene maraleucel for treating relapsed or refractory aggressive B-cell non-Hodgkin lymphoma after 1 systemic treatment when a stem cell transplant is unsuitable (terminated appraisal)
TA1083
23 July 2025
23 July 2025
Pulsed-field ablation for atrial fibrillation
IPG806
10 July 2025
10 July 2025
Mirikizumab for previously treated moderately to severely active Crohn's disease
TA1080
10 July 2025
10 July 2025
Zanubrutinib for treating relapsed or refractory mantle cell lymphoma
TA1081
10 July 2025
10 July 2025
One-piece closed bags for colostomies: late-stage assessment
HTG754
10 July 2025
10 July 2025
Intermittent urethral catheters for chronic incomplete bladder emptying in adults: late-stage assessment
HTG753
9 July 2025
9 July 2025
Dapagliflozin for treating chronic kidney disease
TA1075
2 July 2025
2 July 2025
Adagrasib for previously treated KRAS G12C mutation-positive advanced non-small-cell lung cancer (terminated appraisal)
TA1076
2 July 2025
2 July 2025
Nemolizumab for treating moderate to severe atopic dermatitis in people 12 years and over
TA1077
2 July 2025
2 July 2025
Previous page
1
Current page
2
3
4
…
160
Page
2
of
160
Next page
Results per page
10
25
50
All
Back to top